2m 2m 2m 2m 2m 2m 2m
Bio-Rad Lab-A (BIO)
NYSE
$297.70+$0.12 (+0.04%)
Price as of Jul 13, 2026 6:18 PM EDT- $6.4BMarket Cap
- 18.65%1-Year Change
- Medical DevicesIndustry
Bio-Rad Lab-A (BIO)
$297.70+$0.12 (+0.04%)
BIO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $297.58 | ||
Change | +$1.47 (+0.50%) | ||
Open | $295.17 | ||
High | $299.15 | ||
Low | $292.72 | ||
Previous Close | $296.11 | ||
Volume | 339,946 | ||
30-Day Average Volume | 320,236 | ||
1-Week Change | 0.82% | ||
1-Month Change | 4.07% | ||
1-Year Change | 18.65% | ||
3-Year Change | -25.19% | ||
5-Year Change | -55.22% | ||
Fundamentals | |||
Shares Outstanding | 21.7M | ||
Total Assets | $9.8B | ||
Market Cap | $6.4B | ||
Enterprise Value | $7.1B | ||
Period: QTR TTM FY | |||
Revenue | $592.1M | ||
Net Income | -$527.1M | ||
Free Cash Flow | $78.1M | ||
EBIT | -$677.5M | ||
EBITDA | -$671.6M | ||
Net Working Capital | $2.0B | ||
EPS | -$19.55 | ||
Enterprise Value/EBITDA | -11 | ||
Enterprise Value/Revenue | 12 | ||
P/B | 1 | ||
P/E | -15 | ||
PEG | 0 | ||
Price/Free Cash Flow | 82 | ||
Price/Operating Cash Flow | 59 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue